Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes

Biological Psychiatry

Volumn 55, Issue 6, 2004, Pages 563-569

  Hamidi, Massihullah ^a   Drevets, Wayne C ^b   Price, Joseph L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Astrocyte; Bipolar disorder; Human leukocyte antigen; Microglia; S 100 ; Stereology

Indexed keywords

LEUKOCYTE ANTIGEN; PROTEIN S100B;

ADULT; AGED; ARTICLE; ASTROCYTE; CELL DENSITY; CELL LOSS; CELL NUCLEUS; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEFT HEMISPHERE; MAJOR DEPRESSION; MALE; MICROGLIA; NERVE CELL; NISSL STAINING; OLIGODENDROGLIA; PRIORITY JOURNAL; RIGHT HEMISPHERE; SAMPLING; STATISTICAL SIGNIFICANCE; STEREOMETRY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYGDALA; ASTROCYTES; BIPOLAR DISORDER; CELL COUNT; CELL DEATH; DEPRESSIVE DISORDER, MAJOR; FEMALE; FUNCTIONAL LATERALITY; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROGLIA; OLIGODENDROGLIA; S100 PROTEINS; STAINING AND LABELING;

EID: 1542316019     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.11.006     Document Type: Article

References (60)

1. Abercrombie H.C., Larson C.L., Ward R.T., Shaefer S.M., Holden J.E., Perlman S.B., et al. Metabolic rate in the amygdala predicts negative affect and depression severity in depressed patients An FDG-PET study. Neuroimage. 3:1996;S217.
2. Abercrombie HC, Schaefer SM, Larson CL, Oakes TR, Lindgren KA, Holden JE, et al (1998): Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 9:3301-3307.
3. Aggleton J.P. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 16:1993;328-333.
4. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia. 31:2000;219-231.
5. Bayer TA, Buslei R, Havas L, Falkai P (1999): Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett271:126-128.
6. Bowley M.P., Drevets W.C., Öngür D., Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 52:2002;404-412.
7. Carmichael S.T., Price J.L. Limbic connections to the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol. 363:1995;615-641.
8. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 72:1999;879-882.
9. Cheng J.D., de Vellis J. Oligodendrocytes as glucocorticoids target cells Functional analysis of the glycerol phosphate dehydrogenase gene. J Neurosci Res. 59:2000;436-445.
10. Cotter D., MacKay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry. 58:2001;545-553.
11. Cotter D.R., Pariante C.M., Everall I.P. Glial cell abnormalities in major psychiatric disorders The evidence and implications. Brain Res Bull. 55:2001;585-595.
12. Cotter D.R., MacKay D., Chana G., Beasley C., Landau S., Everall I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 12:2002;386-394.
13. Damadzic R., Bigelow L.B., Krimer L.S., Goldenson D.A., Saunders R.C., Kleinman J.E., Herman M.M. A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression Absence of significant astrocytosis. Brain Res Bull. 55:2001;611-618.
14. Damasio A.R., Grabowski T.J., Bechara A., Damasio H., Ponto L.L.B., Parvizi J., Hichwa R.D. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci. 3:2000;1049-1056.
15. D'Amelio F., Eng L.F., Gibbs M.A. Glutamine synthetase immunoreactivity present in oligodendroglia of various regions of the central nervous system. Glia. 3:1990;335-341.
16. de Olmos J.S. Amygdala. Paxinos G. The Human Nervous System. 1990;583-710 Harcourt Brace Jovanovich, San Diego.
17. Dewar D., Underhill S.M., Goldberg M.P. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab. 23:2003;263-274.
18. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry. 48:2000;813-829.
19. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci. 985:2003;420-444.
20. Drevets W.C., Price J.L., Bardgett M.E., Reich T., Todd R.D., Raichle M.E. Glucose metabolism in the amygdala in depression Relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav. 71:2002;431-447.
21. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
22. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J Neurosci. 12:1992;3628-3641.
23. Frodl T., Meisenzahl E., Zetzsche T., Bottlender R., Born C., Groll C., et al. Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry. 51:2002;708-714.
24. Gundersen H.J.G., Bendtsen T.F., Korbo L., Marcussen N., Moller A., Nielsen K., et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathol Microbiol Immunolog Scand. 96:1988;379-394.
25. Harrison P.J. The neuropathology of primary mood disorder. Brain. 125:2002;1428-1449.
26. Hof P.R., Haroutunian V., Copland C., Davis K.L., Buxbaum J.D. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res. 27:2002;1193-1200.
27. Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP, Davis KL (2003): Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53:1075-1085.
28. Honer W.G., Falkai P., Chen C., Arango V., Mann J.J., Dworks A.J. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience. 91:1999;1247-1255.
29. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry. 5:2000;142-149.
30. Juurlink B.H., Thorburne S.K., Hertz L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia. 22:1998;371-378.
31. LeDoux J. Fear and the brain Where have we been and where are we going? Biol Psychiatry. 44:1998;1229-1238.
32. Ludwin S.K. The function of perineuronal satellite oligodendrocytes An immunohistochemical study. Neuropathol Appl Neurobiol. 10:1984;143-149.
33. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry. 49:2001;97-109.
34. Magistretti P.J., Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B. 354:1999;1155-1163.
35. Manji H.K., Moore G.J., Chen G. Lithium at 50 Have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry. 46:1999;929-940.
36. Marshak D.R. S100 beta as a neurotrophic factor. Prog Brain Res. 86:1990;169-181.
37. Martinez P., Ronsaville D., Gold P.W., Hauser P., Drevets W.C. Morphometric abnormalities in adolescent offspring of depressed mothers. Soc Neuroscience Abstracts. 498:2002;4.
38. Mattiace L.A., Davies P., Dickson D.W. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol. 136:1990;1101-1114.
39. Matute C., Alberdi E., Domercq M., Perez-Cerda F., Perez-Samartin A., Sanchez-Gomez M.V. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24:2001;224-230.
40. Matute C., Sanchez-Gomez M.V., Martinez-Millan L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci. 94:1997;8830-8835.
41. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., Jerabek P.A. Regional metabolic effects of fluoxetine in major depression Serial changes and relationship to clinical response. Biol Psychiatry. 48:2000;830-843.
42. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., et al. Reciprocal limbic-cortical function and negative mood Converging PET findings in depression and normal sadness. Am J Psychiatry. 156:1999;675-682.
43. McDonald J.W., Levine J.M., Qu Y. Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity. Neuroreport. 9:1998;2757-2762.
44. Miguel-Hidalgo J.J., Baucom C., Dilley G., Overholser J.C., Meltzer H.Y., Stockmeier C.A., Rajkowska G. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry. 48:2000;861-873.
45. Miguel-Hidalgo J.J., Wei J., Andrew M., Overholser J.C., Jurjus G., Stockmeier C.A., Rajkowska G. Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry. 52:2002;1121-1133.
46. Murphy B.E. Steroids and depression. J Steroid Biochem Mol Biol. 38:1991;537-559.
47. 18F]FDG PET studies. Psychiatry Res. 91:1999;59-78.
48. Öngür D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci. 95:1998;13290-13295.
49. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav. 43:2003;60-66.
50. Peters A., Palay S.L., Webster HdeF. The Fine Structure of the Nervous System. 1976;WB Saunders, Philadelphia.
51. Raff M. Cell suicide for beginners. Nature. 396:1998;119-122.
52. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 49:2001;741-752.
53. Rajkowska G., Miguel-Hidalgo J.J., Wei J. Morphometric evidence for neuronal and glial prefrontal pathology in major depression. Biol Psychiatry. 45:1999;1085-1098.
54. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C (2002): Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57:127-138.
55. Sheline Y.I., Gado M.H., Price J.L. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport. 9:1998;2023-2028.
56. Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V., Rachmanova V. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 55:2001;597-610.
57. Webster M.J., Knable M.B., Johnston-Wilson N., Nagata K., Inagaki M., Yolken R.H. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immunol. 15:2001;388-400.
58. Yurgelun-Todd D.A., Gruber S.A., Kanayama G., Killgore W.D., Baird A.A., Young A.D. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord. 2:2000;237-248.
59. Zald D.H. The human amygdala and the emotional evaluation of sensory stimuli. Brain Res Rev. 41:2003;88-123.
60. Zimmer D.B., Cornwall E.H., Lander A., Song W. The S100 protein family History, function, and expression. Brain Res Bull. 37:1995;417-429.